![Jason Mellad](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Mellad
Chief Executive Officer at Start Codon Ltd.
Jason Mellad active positions
Companies | Position | Start | End |
---|---|---|---|
Start Codon Ltd.
![]() Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Chief Executive Officer | 30/11/2018 | - |
Founder | 30/11/2018 | - |
Career history of Jason Mellad
Former positions of Jason Mellad
Companies | Position | Start | End |
---|---|---|---|
Biomodal Ltd.
![]() Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 31/07/2016 | 31/12/2018 |
Chief Executive Officer | 31/07/2016 | 31/12/2018 | |
Corporate Officer/Principal | 31/07/2016 | - | |
Horizon Discovery Ltd.
![]() Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Jason Mellad
University of Cambridge | Doctorate Degree |
Tulane University (Louisiana) | Undergraduate Degree |
Statistics
International
United Kingdom | 5 |
United States | 2 |
Operational
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectoral
Commercial Services | 3 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Biomodal Ltd.
![]() Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Horizon Discovery Ltd.
![]() Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Start Codon Ltd.
![]() Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Finance |
- Stock Market
- Insiders
- Jason Mellad
- Experience